Apyx Medical Corporation (APYX)
USD 0.92
(3.98%)
USD 0.92
(3.98%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 79.24 Million USD | 53.05% |
| 2022 | 51.77 Million USD | -24.66% |
| 2021 | 68.72 Million USD | -7.27% |
| 2020 | 74.11 Million USD | -12.48% |
| 2019 | 84.67 Million USD | -11.44% |
| 2018 | 95.61 Million USD | 208.54% |
| 2017 | 30.98 Million USD | -11.74% |
| 2016 | 35.11 Million USD | 11.64% |
| 2015 | 31.44 Million USD | 26.64% |
| 2014 | 24.83 Million USD | -25.15% |
| 2013 | 33.17 Million USD | 17.72% |
| 2012 | 28.18 Million USD | -0.2% |
| 2011 | 28.24 Million USD | 1.63% |
| 2010 | 27.78 Million USD | 0.73% |
| 2009 | 27.58 Million USD | 7.0% |
| 2008 | 25.77 Million USD | 36.97% |
| 2007 | 18.82 Million USD | 12.8% |
| 2006 | 16.68 Million USD | 41.75% |
| 2005 | 11.77 Million USD | 6.82% |
| 2004 | 11.01 Million USD | 19.33% |
| 2003 | 9.23 Million USD | 8.62% |
| 2002 | 8.5 Million USD | -0.91% |
| 2001 | 8.57 Million USD | 8.4% |
| 2000 | 7.91 Million USD | 7.76% |
| 1999 | 7.34 Million USD | -31.11% |
| 1998 | 10.65 Million USD | 177.77% |
| 1997 | 3.83 Million USD | -1.57% |
| 1996 | 3.89 Million USD | 8.28% |
| 1995 | 3.6 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 65.39 Million USD | -7.52% |
| 2024 Q1 | 70.71 Million USD | -10.76% |
| 2023 Q2 | 62.42 Million USD | 9.94% |
| 2023 Q4 | 79.24 Million USD | 33.3% |
| 2023 Q1 | 56.78 Million USD | 9.67% |
| 2023 FY | 79.24 Million USD | 53.05% |
| 2023 Q3 | 59.44 Million USD | -4.78% |
| 2022 Q1 | 62.99 Million USD | -8.33% |
| 2022 Q2 | 59.47 Million USD | -5.6% |
| 2022 Q3 | 55.26 Million USD | -7.07% |
| 2022 Q4 | 51.77 Million USD | -6.32% |
| 2022 FY | 51.77 Million USD | -24.66% |
| 2021 Q4 | 68.72 Million USD | 1.4% |
| 2021 FY | 68.72 Million USD | -7.27% |
| 2021 Q1 | 71.09 Million USD | -4.07% |
| 2021 Q2 | 69.59 Million USD | -2.11% |
| 2021 Q3 | 67.76 Million USD | -2.63% |
| 2020 Q1 | 82.11 Million USD | -3.02% |
| 2020 Q2 | 77.82 Million USD | -5.22% |
| 2020 Q3 | 75.41 Million USD | -3.1% |
| 2020 Q4 | 74.11 Million USD | -1.73% |
| 2020 FY | 74.11 Million USD | -12.48% |
| 2019 FY | 84.67 Million USD | -11.44% |
| 2019 Q4 | 84.67 Million USD | -2.61% |
| 2019 Q3 | 86.94 Million USD | -2.18% |
| 2019 Q2 | 88.88 Million USD | -3.08% |
| 2019 Q1 | 91.7 Million USD | -4.09% |
| 2018 Q1 | 30.11 Million USD | -2.83% |
| 2018 FY | 95.61 Million USD | 208.54% |
| 2018 Q4 | 95.61 Million USD | -15.47% |
| 2018 Q3 | 113.11 Million USD | 269.0% |
| 2018 Q2 | 30.65 Million USD | 1.8% |
| 2017 Q2 | 32.55 Million USD | -1.62% |
| 2017 Q3 | 30.69 Million USD | -5.7% |
| 2017 Q4 | 30.98 Million USD | 0.94% |
| 2017 FY | 30.98 Million USD | -11.74% |
| 2017 Q1 | 33.09 Million USD | -5.75% |
| 2016 FY | 35.11 Million USD | 11.64% |
| 2016 Q1 | 29.74 Million USD | -5.42% |
| 2016 Q2 | 29.59 Million USD | -0.52% |
| 2016 Q3 | 29.14 Million USD | -1.49% |
| 2016 Q4 | 35.11 Million USD | 20.45% |
| 2015 FY | 31.44 Million USD | 26.64% |
| 2015 Q3 | 33.12 Million USD | -2.95% |
| 2015 Q2 | 34.12 Million USD | -1.33% |
| 2015 Q1 | 34.58 Million USD | 39.28% |
| 2015 Q4 | 31.44 Million USD | -5.05% |
| 2014 Q4 | 24.83 Million USD | -20.64% |
| 2014 Q3 | 31.29 Million USD | -0.97% |
| 2014 Q2 | 31.59 Million USD | -2.8% |
| 2014 FY | 24.83 Million USD | -25.15% |
| 2014 Q1 | 32.5 Million USD | -2.01% |
| 2013 Q1 | 28.07 Million USD | -0.37% |
| 2013 Q3 | 27.68 Million USD | -0.86% |
| 2013 Q4 | 33.17 Million USD | 19.83% |
| 2013 FY | 33.17 Million USD | 17.72% |
| 2013 Q2 | 27.92 Million USD | -0.54% |
| 2012 Q4 | 28.18 Million USD | 0.51% |
| 2012 FY | 28.18 Million USD | -0.2% |
| 2012 Q1 | 27.98 Million USD | -0.9% |
| 2012 Q2 | 28.03 Million USD | 0.18% |
| 2012 Q3 | 28.04 Million USD | 0.01% |
| 2011 Q2 | 28.64 Million USD | 1.33% |
| 2011 FY | 28.24 Million USD | 1.63% |
| 2011 Q4 | 28.24 Million USD | -1.1% |
| 2011 Q3 | 28.55 Million USD | -0.33% |
| 2011 Q1 | 28.27 Million USD | 1.76% |
| 2010 Q1 | 27.68 Million USD | 0.38% |
| 2010 FY | 27.78 Million USD | 0.73% |
| 2010 Q3 | 29.4 Million USD | 0.62% |
| 2010 Q4 | 27.78 Million USD | -5.49% |
| 2010 Q2 | 29.21 Million USD | 5.53% |
| 2009 Q2 | 27.61 Million USD | 4.07% |
| 2009 FY | 27.58 Million USD | 7.0% |
| 2009 Q3 | 27.19 Million USD | -1.52% |
| 2009 Q4 | 27.58 Million USD | 1.42% |
| 2009 Q1 | 26.53 Million USD | 2.94% |
| 2008 Q2 | 21.21 Million USD | 8.23% |
| 2008 Q4 | 25.77 Million USD | 3.63% |
| 2008 FY | 25.77 Million USD | 36.97% |
| 2008 Q1 | 19.6 Million USD | 4.16% |
| 2008 Q3 | 24.87 Million USD | 17.24% |
| 2007 Q1 | 17.65 Million USD | 5.8% |
| 2007 FY | 18.82 Million USD | 12.8% |
| 2007 Q2 | 18.48 Million USD | 4.69% |
| 2007 Q3 | 18.86 Million USD | 2.1% |
| 2007 Q4 | 18.82 Million USD | -0.26% |
| 2006 Q1 | 12.7 Million USD | 7.97% |
| 2006 Q2 | 13.42 Million USD | 5.6% |
| 2006 Q3 | 14.77 Million USD | 10.09% |
| 2006 FY | 16.68 Million USD | 41.75% |
| 2006 Q4 | 16.68 Million USD | 12.93% |
| 2005 Q3 | 11.6 Million USD | 1.35% |
| 2005 Q4 | 11.77 Million USD | 1.44% |
| 2005 Q2 | 11.44 Million USD | 0.3% |
| 2005 Q1 | 11.41 Million USD | 3.59% |
| 2005 FY | 11.77 Million USD | 6.82% |
| 2004 Q2 | 10.42 Million USD | 4.26% |
| 2004 Q1 | 9.99 Million USD | 8.29% |
| 2004 Q4 | 11.01 Million USD | 2.61% |
| 2004 Q3 | 10.73 Million USD | 3.01% |
| 2004 FY | 11.01 Million USD | 19.33% |
| 2003 FY | 9.23 Million USD | 8.62% |
| 2003 Q1 | 9.07 Million USD | 6.7% |
| 2003 Q4 | 9.23 Million USD | 0.27% |
| 2003 Q3 | 9.2 Million USD | 2.37% |
| 2003 Q2 | 8.99 Million USD | -0.82% |
| 2002 Q2 | 8.61 Million USD | 1.03% |
| 2002 Q4 | 8.5 Million USD | -3.0% |
| 2002 FY | 8.5 Million USD | -0.91% |
| 2002 Q3 | 8.76 Million USD | 1.68% |
| 2002 Q1 | 8.53 Million USD | -0.55% |
| 2001 FY | 8.57 Million USD | 8.4% |
| 2001 Q1 | 7.94 Million USD | 0.37% |
| 2001 Q2 | 8.17 Million USD | 2.94% |
| 2001 Q3 | 8.39 Million USD | 2.63% |
| 2001 Q4 | 8.57 Million USD | 2.24% |
| 2000 Q4 | 7.91 Million USD | 2.12% |
| 2000 Q1 | 7.47 Million USD | 2.36% |
| 2000 FY | 7.91 Million USD | 7.76% |
| 2000 Q3 | 7.74 Million USD | -1.0% |
| 2000 Q2 | 7.82 Million USD | 4.76% |
| 1999 FY | 7.34 Million USD | -31.11% |
| 1999 Q1 | 10.7 Million USD | 0.0% |
| 1999 Q2 | 10.7 Million USD | 0.0% |
| 1999 Q3 | 8.8 Million USD | -17.76% |
| 1999 Q4 | 7.3 Million USD | -17.05% |
| 1998 Q1 | 7.8 Million USD | 105.26% |
| 1998 Q2 | 10.9 Million USD | 39.74% |
| 1998 Q3 | 11.1 Million USD | 1.83% |
| 1998 Q4 | 10.7 Million USD | -3.6% |
| 1998 FY | 10.65 Million USD | 177.77% |
| 1997 Q2 | 4.1 Million USD | -2.38% |
| 1997 Q1 | 4.2 Million USD | 7.69% |
| 1997 Q4 | 3.8 Million USD | -5.0% |
| 1997 FY | 3.83 Million USD | -1.57% |
| 1997 Q3 | 4 Million USD | -2.44% |
| 1996 Q2 | 3.7 Million USD | 2.78% |
| 1996 FY | 3.89 Million USD | 8.28% |
| 1996 Q3 | 3.7 Million USD | 0.0% |
| 1996 Q1 | 3.6 Million USD | 0.0% |
| 1996 Q4 | 3.9 Million USD | 5.41% |
| 1995 Q4 | 3.6 Million USD | 0.0% |
| 1995 FY | 3.6 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| BrainsWay Ltd. | 62.97 Million USD | -25.834% |
| Envoy Medical, Inc. | 7.64 Million USD | -937.173% |
| Bioventus Inc. | 810.91 Million USD | 90.228% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -35.081% |
| MaxCyte, Inc. | 268.27 Million USD | 70.463% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -238.653% |
| Cerus Corporation | 197.74 Million USD | 59.929% |
| Sight Sciences, Inc. | 166.65 Million USD | 52.452% |
| SI-BONE, Inc. | 230.42 Million USD | 65.611% |
| CVRx, Inc. | 115.22 Million USD | 31.233% |
| OrthoPediatrics Corp. | 449.58 Million USD | 82.375% |
| NanoVibronix, Inc. | 6.67 Million USD | -1087.294% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 63.759% |
| Orthofix Medical Inc. | 925.31 Million USD | 91.436% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -2443.614% |
| Acutus Medical, Inc. | 53.96 Million USD | -46.85% |
| Talis Biomedical Corporation | 98.34 Million USD | 19.422% |
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -152.63% |
| electroCore, Inc. | 16.38 Million USD | -383.554% |
| Inogen, Inc. | 326.19 Million USD | 75.708% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -190.576% |
| Spectral AI, Inc. | 10.69 Million USD | -641.115% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -377.954% |
| Nexalin Technology, Inc. | 3.63 Million USD | -2081.769% |
| PAVmed Inc | 33.11 Million USD | -139.258% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 44.762% |
| RxSight, Inc. | 182.55 Million USD | 56.593% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -208.027% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 68.544% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -638.49% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -930.161% |
| IceCure Medical Ltd | 16.41 Million USD | -382.876% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -878.596% |
| TELA Bio, Inc. | 78.04 Million USD | -1.527% |
| Venus Concept Inc. | 93.65 Million USD | 15.391% |
| LivaNova PLC | 2.42 Billion USD | 96.739% |
| 908 Devices Inc. | 202.98 Million USD | 60.962% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 90.159% |
| Nemaura Medical Inc. | 14.56 Million USD | -444.11% |
| NeuroPace, Inc. | 107.65 Million USD | 26.392% |
| LENSAR, Inc. | 69.58 Million USD | -13.875% |
| Cutera, Inc. | 346.29 Million USD | 77.118% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -88.595% |
| BioSig Technologies, Inc. | 1.79 Million USD | -4307.119% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 70.72% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -85.743% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 97.905% |
| Axonics, Inc. | 719.92 Million USD | 88.993% |
| Outset Medical, Inc. | 313.8 Million USD | 74.748% |
| IRIDEX Corporation | 34.43 Million USD | -130.108% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 80.421% |
| IRadimed Corporation | 92.15 Million USD | 14.015% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -1408.184% |
| INVO Bioscience, Inc. | 20.88 Million USD | -279.36% |
| Telesis Bio, Inc. | 70.41 Million USD | -12.539% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 48.58% |
| Varex Imaging Corporation | 1.24 Billion USD | 93.659% |
| Quipt Home Medical Corp. | 247.4 Million USD | 67.972% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -751.128% |
| Pulmonx Corporation | 178.95 Million USD | 55.72% |
| Dynatronics Corporation | 25.94 Million USD | -205.468% |
| Modular Medical, Inc. | 13.8 Million USD | -473.912% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -638.697% |
| Semler Scientific, Inc. | 78.06 Million USD | -1.505% |
| InMode Ltd. | 863.28 Million USD | 90.821% |
| Bruker Corporation | 4.24 Billion USD | 98.135% |
| Cytosorbents Corporation | 53.26 Million USD | -48.778% |
| DexCom, Inc. | 6.26 Billion USD | 98.735% |
| Align Technology, Inc. | 6.08 Billion USD | 98.698% |
| Viveve Medical, Inc. | 25.91 Million USD | -205.792% |
| ZimVie Inc. | 1.2 Billion USD | 93.426% |
| Movano Inc. | 9.42 Million USD | -741.1% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 84.078% |
| Nexalin Technology, Inc. | 3.63 Million USD | -2081.769% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -35.081% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 91.682% |
| Profound Medical Corp. | 43.68 Million USD | -81.384% |
| Insulet Corporation | 2.58 Billion USD | 96.938% |
| enVVeno Medical Corporation | 48.63 Million USD | -62.928% |
| Surmodics, Inc. | 185.73 Million USD | 57.337% |
| iCAD, Inc. | 41.41 Million USD | -91.318% |
| Nuwellis, Inc. | 9.77 Million USD | -711.054% |
| Biotricity, Inc. | 5.94 Million USD | -1233.417% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 81.706% |
| Aethlon Medical, Inc. | 8.24 Million USD | -860.953% |
| InspireMD, Inc. | 47.64 Million USD | -66.32% |
| PAVmed Inc. | 33.11 Million USD | -139.258% |
| BIOLASE, Inc. | 35.1 Million USD | -125.749% |
| Beyond Air, Inc. | 56.96 Million USD | -39.113% |
| FONAR Corporation | 214.24 Million USD | 63.014% |
| AxoGen, Inc. | 196.82 Million USD | 59.741% |
| Vivani Medical, Inc. | 45.79 Million USD | -73.024% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 71.845% |
| Inari Medical, Inc. | 674.23 Million USD | 88.247% |
| UFP Technologies, Inc. | 404.13 Million USD | 80.393% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -733.832% |
| Tenon Medical, Inc. | 6.34 Million USD | -1148.857% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -742.351% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 23.549% |
| AdaptHealth Corp. | 4.61 Billion USD | 98.285% |
| Sintx Technologies, Inc. | 15.36 Million USD | -415.718% |
| Quanterix Corporation | 425.01 Million USD | 81.356% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -751.128% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -47.486% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 95.462% |
| TransMedics Group, Inc. | 706.04 Million USD | 88.777% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -25.396% |
| NeuroMetrix, Inc. | 21.42 Million USD | -269.858% |
| Hyperfine, Inc. | 94.19 Million USD | 15.88% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 70.503% |
| Biomerica, Inc. | 9.25 Million USD | -756.278% |
| Bone Biologics Corporation | 3.73 Million USD | -2019.985% |
| AVITA Medical, Inc. | 144.33 Million USD | 45.102% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -1527.596% |
| Silk Road Medical, Inc | 265.3 Million USD | 70.133% |